Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

TriGUARD 3 Data Does Not Pass Muster: FDA Experts

Aug 05 2021

Keystone Heart's TriGUARD 3 limited trial data showed serious safety concerns — • Source: Keystone Heart

Additional Topics

United States Regulation Research & Development Advisory Committees Companies Clinical Trials FDA Innovation Review Pathway Safety Cardiovascular Cardiology Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window